Garcia Hernandez I reported a 48-year-old HER2 positive mucinous carcinoma patient who received neoadjuvant chemotherapy based on trastuzumab and pertuzumab, but she had almost no pathological response [14]. The gene discussed is ERBB2; the disease is mucinous adenocarcinoma.